Adaptive Therapeutics Inc (AKA: NanoRX Therapeutics) Profile last edited on: 11/25/2014
CAGE:
UEI:
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
5820 Nancy Ridge Drive Suite 200
San Diego, CA 92121
San Diego, CA 92121
| (858) 909-9050 |
| N/A |
| www.adaptivetherapeutics.com |
Location: Single
Congr. District: 51
County: San Diego
Congr. District: 51
County: San Diego
Public Profile
Adaptive Therapeutics Inc. (ATI) founding technology was developed in Professor M. Reza Ghadiri's laboratory and the company negotiated and secured exclusive worldwide licenses from The Scripps Research Institute (TSRI) to intellectual property rights covering anti-bacterial, anti-fungal, anti-viral, and anti-cancer therapeutic applications of Adaptide peptides
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2003 | 1 | NIH | $100,000 | |
| Project Title: Antifungal Activity of Cyclic D,L-alpha Peptides | ||||
Key People / Management
Noubar Afeyan -- President
Jorge Sanchez-Quesada
Jorge Sanchez-Quesada
Company News
There are no news available.
